Obesity Archives - Page 2 of 134 - MPR

Obesity

Saxenda Approved for Obesity in Adolescent Patients

The FDA has approved Saxenda® (liraglutide; Novo Nordisk) as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in patients aged 12 years and older with body weight >60kg and an initial BMI corresponding to ≥30kg/m2 for adults (obese).